Oral GLP-1 for Men: What Guys Need to Know About the Pill vs the Shot

There's no sex-based dosing difference for oral GLP-1s — the trials behind Rybelsus, the Wegovy pill, and Foundayo all enrolled both men and women, and dosing is based on the same titration schedule regardless of sex. What's genuinely worth understanding if you're a man considering the oral route: where the hormonal research actually applies, and a needle-aversion factor that doesn't always get talked about openly.

The Testosterone Connection — and an Important Caveat

One of the more compelling findings in GLP-1 research over the past two years is what weight loss does to testosterone in men with obesity. Fat tissue contains an enzyme called aromatase that converts testosterone into estrogen — more body fat means more of this conversion, which is a major driver of low testosterone in men with obesity. In one published cohort of 234 men on GLP-1 therapy, total testosterone rose from an average of 312 ng/dL to 368 ng/dL, and the proportion of men with normal testosterone levels increased from 53% to 77%. A separate controlled study found tirzepatide outperformed testosterone replacement therapy itself on weight loss and erectile function, while restoring natural testosterone production rather than replacing it externally — and, notably, preserving sperm quality in a way TRT did not.

The important caveat: this research was conducted on GLP-1 therapy broadly — primarily the injectable formulations most study participants were using — not on oral GLP-1s specifically. The mechanism itself (less body fat → less aromatase activity → less testosterone converted to estrogen) is a function of weight loss, not of how the drug enters your body. That gives a reasonable scientific basis to expect a comparable hormonal benefit from an oral option that achieves similar weight loss — but no published study has directly measured testosterone changes in men using Rybelsus, the Wegovy pill, or Foundayo specifically. If restoring testosterone through weight loss is a major part of your motivation, know that you're extrapolating from the broader GLP-1 evidence base, not from oral-specific trial data.

Needle Aversion: A Real Factor That's Rarely Discussed Openly

Needle phobia affects roughly 1 in 4 adults across published surveys, and there's no strong evidence it's less common in men — if anything, social expectations around masculinity can make it a harder thing for men to admit to a provider or even to themselves. If avoiding an injection is part of what's kept you from starting a GLP-1 at all, that's a legitimate reason to consider the oral route, not something to feel like you need to justify further. We cover the full needle-aversion picture, including how modern injector pens have actually gotten less painful, in our no-injection guide.

Choosing Between Oral Options as a Man

The decision framework here isn't meaningfully different by sex — the same trade-offs between FDA-approved pills (Foundayo, Wegovy pill) and compounded oral options (sublingual drops, dissolvable tablets, capsules) apply regardless of who's taking them. What might matter more to you specifically:

• If the testosterone angle is a real motivator, know that meaningful weight loss — achieved through any effective GLP-1, oral or injectable — is what drives the hormonal benefit, not the specific pill format.
• If you're on testosterone replacement therapy already, talk to your prescriber before starting a GLP-1 — the research suggests GLP-1 therapy may reduce your need for TRT over time as your body's own production recovers, which changes your treatment plan rather than simply adding to it.
• If avoiding needles has kept you from starting anything at all, the full oral lineup — FDA-approved and compounded — removes that barrier completely.

Bottom Line

Oral GLP-1s work the same way in men as in anyone else, and the emerging testosterone and fertility research is genuinely encouraging — but it's research on GLP-1 therapy and weight loss broadly, not a claim specific to the oral pill format. If needle aversion is what's held you back, that alone is a good enough reason to go oral. For the full comparison of every option, see our complete oral GLP-1 guide.